Abstract 3623: Quantifying pharmacodynamic markers of radioligand therapies in tumor by multiplex immunofluorescence and automated quantitative analysis (AQUA) algorithms
James Santos, Jennifer Bordeaux(Lineage Cell Therapeutics (United States)), Ernesta Dammassa(Novartis (Switzerland)), Margaret McLaughlin(University of Southern California), Naveen Dakappagari(Navidea Biopharmaceuticals (United States)), Lisa Kattenhorn(American Institutes for Research), Lori A. Iaconis, Vincent Romanet(Novartis (Switzerland)), Emmanuel Pacia, James Deeds, Virginia Nyanchama, Xun Li, Ying Huang, Jimmie Lim
Cited by 0
Related Papers
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
|Nature Medicine|2015|1.4k
Antibody validation
|BioTechniques|2010|601
Linear Motif Atlas for Phosphorylation-Dependent Signaling
|Science Signaling|2008|465